Bringing the fundamentals into focus…
Back to Benitec Biopharma Inc.
How Benitec Biopharma Inc. stacks up
BNTC · against 344 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #213 of 345 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score133 peers with a valuation score of 0–9, including BNTC · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -44.9% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -11.7% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -5.7% vs peer median 0.0%
Metric by metric
Position: dot = BNTC, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BNTC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 330 reported | -11.7% | -0.4% | 28% | 30% | |
| EBITDA yieldHigher is better · 351 reported | -44.9% | 1.8% | 10% | 50% | |
| Free cash flow yieldHigher is better · 178 reported | -5.7% | -9.3% | 59% | 20% | |
| Book yieldHigher is better · 338 reported | 61.2% | 51.5% | 57% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around BNTC| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 213 | 377M USD | 8 | 29 | |
| 213 | 334M USD | 8 | 36 | |
| 213 | 546M USD | 8 | 31 | |
| 213 | 222M USD | 8 | 31 | |
| 213 | 293M USD | 8 | ||
| 213 | 241M USD | 8 | ||
| 213 | 479M USD | 8 | 34 | |
| 213 | 393M USD | 8 | 50 | |
| 213 | 395M USD | 8 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score